Showing results (501-510 of 545) with videos related to

Sort By:
Pageof 55
Nature Neuroscience|September 15, 2009
Nicotine activates the chemosensory cation channel TRPA1Karel Talavera, Maarten Gees, Yuji Karashima, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2024
Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancerNiloefar Ahmadi Bidakhvidi, Thomas Gevaert, Maxim De Schepper, et al.
EJNMMI Research|April 30, 2021
Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancerNiloefar Ahmadi Bidakhvidi, Annouschka Laenen, Sander Jentjens, et al.
Clinical Neurology and Neurosurgery|July 25, 2013
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosisDirk De Ridder, Frank Van Der Aa, Jan Debruyne, et al.
The Journal of Urology|November 14, 2019
Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node DissectionCédric Draulans, Wouter Everaerts, Sofie Isebaert, et al.
BMC Cancer|April 3, 2018
Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trialLorenzo Tosco, Annouschka Laenen, Thomas Gevaert, et al.
Neurourology and Urodynamics|July 1, 2010
Overactive bladder: Is there a link to the metabolic syndrome in men?Michael G Kirby, Adrian Wagg, Linda Cardozo, et al.
European Urology|November 30, 2006
Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ)Ramandeep Basra, Walter Artibani, Linda Cardozo, et al.
Clinical Nuclear Medicine|February 1, 2023
A Drop-in Gamma Probe for Minimally Invasive Sentinel Lymph Node Dissection in Prostate Cancer: Preclinical Evaluation and Interim Results From a Multicenter Clinical TrialJose M Abascal Junquera, Nina N Harke, Jochen C Walz, et al.
World Journal of Urology|March 13, 2019
Metastasectomy for visceral and skeletal oligorecurrent prostate cancerAntonino Battaglia, Gaëtan Devos, Karel Decaestecker, et al.
Pageof 55